Randomized Study of the Efficacy and Safety of a Single Dose of Synvisc-One® in Chinese Patients With Symptomatic Osteoarthritis of the Knee
Clinical trial NCT03190369 · COMPLETED
Trial details
- NCT number
- NCT03190369
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-21
- Primary completion
- 2019-01-28
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.